In:
médecine/sciences, EDP Sciences, Vol. 36, No. 8-9 ( 2020-08), p. 753-762
Abstract:
Macular edema is an increase in volume of the central area of the retina, responsible for visual acuity. Visual symptoms handicap the lives of millions of patients with macular edema secondary to chronic and sometimes acute retinal disease. Proteins that neutralize the vascular endothelial growth factor (VEGF) pathway or glucocorticoids, at the cost of repeated intraocular injections over years, limit visual symptoms. A better understanding of why and how edema forms and how therapeutic molecules exert an anti-edematous effect will help prevent this disabling and blinding retinal complication from occurring.
Type of Medium:
Online Resource
ISSN:
0767-0974
,
1958-5381
DOI:
10.1051/medsci/2020130
Language:
French
Publisher:
EDP Sciences
Publication Date:
2020
detail.hit.zdb_id:
2049442-7
